Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 17, 2021
Bryant Ranch Prepack is voluntarily recalling in total 47 bottles of Spironolactone tablets to the consumer level.
read more
Wednesday, March 17, 2021
CGT Catapult announced GSK will leverage the CGT Catapult Stevenage facility to perform GMP cell processing to accelerate its cell and gene therapy pipeline for clinical trials.
read more
Wednesday, March 17, 2021
Jubilant Life Sciences has signed new contract with Eli Lilly for contract manufacturing of a treatment for COVID-19.
read more
Wednesday, March 17, 2021
Altimmune has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza.
read more
Wednesday, March 17, 2021
HomTex has received EUA for its Level 1 Surgical masks, greenlighting their entry into the US government and medical PPE markets.
read more
AGC Chemicals now offers small-molecule API contract manufacturing services.
read more
Catalent announced an expanded partnership with Janssen Pharmaceutica and Janssen Pharmaceuticals whereby Catalent will increase the manufacturing capacity for large-scale commercial supply of Janssen’s COVID-19 vaccine at Catalent’s manufacturing ...
read more
Aptamer Group announced a commercial partnership with Mologic, a developer and manufacturer of lateral flow and rapid diagnostic tests.
read more
Catalent has signed an agreement with Cybin to apply Catalent’s proprietary Zydis ODT technology for the delivery of Cybin’s novel deuterated tryptamine.
read more
PPL's, Piramal Pharma Solutions, announced the Company has entered into a Master Services Agreement.
read more
The FDA has proposed to include one additional bulk drug substance on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug and Cosmetic Act.
read more
CyanVac announced they have selected Exothera for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector.
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
Wednesday, March 31, 2021
TCR2 Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.
read more
Wednesday, March 31, 2021
Albumedix announced they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako.
read more